iPAG
Who is iPAG?
iPAG Position Statement
Diabetes
What is Type 1 Diabetes?
Type 2 Diabetes
Gestational Diabetes
MODY – Maturity onset diabetes of the young
Insulin Pump Therapy
Pumps available in Scotland & the UK
Comparison chart of all pumps available in the UK 2016
Insulin Pump and Continuous Glucose Monitor contracts NHS Scotland 2018
Benefits and disadvantages of insulin pump therapy
Getting a pump in Scotland
Healthboard Post-Warranty Insulin Pump Replacement Policy
CGM
Continuous glucose monitoring in the UK
Getting Continuous Glucose Monitoring in Scotland
NICE guidelines & funding CGM
Dexcom G5
Search
Friday, March 14, 2025
Blog
Useful info
Contact iPAG
iPAG Scotland
iPAG
Who is iPAG?
iPAG Position Statement
Diabetes
What is Type 1 Diabetes?
Type 2 Diabetes
Gestational Diabetes
MODY – Maturity onset diabetes of the young
Insulin Pump Therapy
Pumps available in Scotland & the UK
Comparison chart of all pumps available in the UK 2016
Insulin Pump and Continuous Glucose Monitor contracts NHS Scotland 2018
Benefits and disadvantages of insulin pump therapy
Getting a pump in Scotland
Healthboard Post-Warranty Insulin Pump Replacement Policy
CGM
Continuous glucose monitoring in the UK
Getting Continuous Glucose Monitoring in Scotland
NICE guidelines & funding CGM
Dexcom G5
News
Latest
Page 2
Latest
Latest news
Minimed Mio Advance infusion sets
Funding for CGMs and Adult Insulin Pumps 2017
SNP announce 10 million funding for diabetes technology Dec 2016
Next step to Artificial Pancreas – 670G is FDA approved
Experts Recommend Continuous Glucose Monitors for Adults with Type 1 Diabetes
Insulin pump usage per health board 2016
Continuous glucose monitoring in the UK
Type 1 diabetics have ‘sleeping’ insulin cells which could be woken,...
Beyond Type 1 – Online Global Community
CellNovo partners with TypeZero on Artificial Pancreas Programme
Pump Experiences
Medtronic acquire Diabeter
1
2
3
Page 2 of 3
